400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2022-07-13
临床阶段生物制药商
医药研发/制造
化学&生物药
Invus;
Invus;
Boxer Capital;
Boxer Capital;
EcoR1 Capital;
New Enterprise Associate;
Monashee Investment Management;
Rock Springs Capital;
Madison Avenue Partners;
Weiss Asset Management
2022-03-16
肿瘤治疗新药研发商
医药研发/制造
化学&生物药
Boxer Capital;
Boxer Capital;
Armistice Capital;
Armistice Capital;
RTW Investments;
SynBio Innovation Accelerator;
Heights Capital Management;
Nick Leschly & family;
EcoR1 Capital;
Cowen Healthcare Investments;
Janus Henderson Investors;
CaaS;
Bain Capital;
Newtyn Management;
683 Capital;
Madison Avenue Partners
生物天使2026-01-25
广州医科大学附属第二医院2026-01-25
晨哨并购2026-01-24
动脉橙果局2026-01-24
蒲公英Ouryao2026-01-24
Antibody Research2026-01-24
医药云端工作室2026-01-24
精准药物2026-01-24
医药笔记2026-01-24
生物天使2026-01-24